| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
|
Teunissen, Charlotte E
|
|
|
21 |
1 |
p. 66-77
|
artikel
|
| 2 |
Correction to Lancet Neurol 2021; 20: 762–72
|
|
|
|
21 |
1 |
p. e1
|
artikel
|
| 3 |
Correction to Lancet Neurol 2021; 20: 917–29
|
|
|
|
21 |
1 |
p. e1
|
artikel
|
| 4 |
Development of treatments for Down syndrome
|
Rafii, Michael S
|
|
|
21 |
1 |
p. 22-23
|
artikel
|
| 5 |
Epilepsy research in 2021: multidisciplinary achievements
|
Ikeda, Akio
|
|
|
21 |
1 |
p. 8-10
|
artikel
|
| 6 |
Following in the footsteps of neuroscience giants
|
Ranscombe, Peter
|
|
|
21 |
1 |
p. 30
|
artikel
|
| 7 |
Headache in 2021: clinical, biological, and genetic advances
|
De Icco, Roberto
|
|
|
21 |
1 |
p. 6-8
|
artikel
|
| 8 |
Highlights in traumatic brain injury research in 2021
|
Ponsford, Jennie
|
|
|
21 |
1 |
p. 5-6
|
artikel
|
| 9 |
Idiopathic hypersomnia: does first to approval mean first-line treatment?
|
Trotti, Lynn Marie
|
|
|
21 |
1 |
p. 25-26
|
artikel
|
| 10 |
Important advances in sleep research in 2021
|
West, Leslie C
|
|
|
21 |
1 |
p. 15-17
|
artikel
|
| 11 |
Kathleen Friel
|
|
|
|
21 |
1 |
p. 28
|
artikel
|
| 12 |
Lars Edvinsson: bench-to-bedside discovery
|
Samarasekera, Udani
|
|
|
21 |
1 |
p. 27
|
artikel
|
| 13 |
Major research advances in amyotrophic lateral sclerosis in 2021
|
Petri, Susanne
|
|
|
21 |
1 |
p. 14-15
|
artikel
|
| 14 |
2021 marks a new era for Alzheimer's therapeutics
|
Kantarci, Kejal
|
|
|
21 |
1 |
p. 3-4
|
artikel
|
| 15 |
Movement disorders research in 2021: cracking the paradigm
|
Espay, Alberto J
|
|
|
21 |
1 |
p. 10-11
|
artikel
|
| 16 |
Multiple sclerosis in 2021: progress against progression
|
Beck, Erin S
|
|
|
21 |
1 |
p. 12-13
|
artikel
|
| 17 |
Neurological infections in 2021: a spotlight on India
|
Garg, Ravindra Kumar
|
|
|
21 |
1 |
p. 17-18
|
artikel
|
| 18 |
Neurology and the climate emergency
|
The Lancet Neurology,
|
|
|
21 |
1 |
p. 1
|
artikel
|
| 19 |
Neuroscience in the 21st century: circuits, computation, and behaviour
|
Kanter, Benjamin R
|
|
|
21 |
1 |
p. 19-21
|
artikel
|
| 20 |
Risdiplam: new opportunities but more to be done
|
Sansone, Valeria A
|
|
|
21 |
1 |
p. 23-24
|
artikel
|
| 21 |
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study
|
Dauvilliers, Yves
|
|
|
21 |
1 |
p. 53-65
|
artikel
|
| 22 |
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
|
Mercuri, Eugenio
|
|
|
21 |
1 |
p. 42-52
|
artikel
|
| 23 |
Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial
|
Costa, Alberto C S
|
|
|
21 |
1 |
p. 31-41
|
artikel
|
| 24 |
Sleep apnoea and ischaemic stroke: current knowledge and future directions
|
Baillieul, Sébastien
|
|
|
21 |
1 |
p. 78-88
|
artikel
|
| 25 |
Stroke research in 2021: insights into the reorganisation of stroke care
|
Puy, Laurent
|
|
|
21 |
1 |
p. 2-3
|
artikel
|
| 26 |
The neuropsychiatry of Parkinson's disease: advances and challenges
|
Weintraub, Daniel
|
|
|
21 |
1 |
p. 89-102
|
artikel
|
| 27 |
Vivid dreaming
|
Morgan, Jules
|
|
|
21 |
1 |
p. 29
|
artikel
|
| 28 |
50 years of intelligence gone
|
Drouin, Emmanuel
|
|
|
21 |
1 |
p. 28
|
artikel
|
Tijdschrift beschrijving